Table 1.

Patient, virological and clinical characteristics

Patient	Age*	HCV†	Genotype	YMDD‡	Lamivudine duration§
1	43	Yes	A	Yes	8
2	48	No	A	Yes	7
3	41	Yes	A	Yes	6
4	43	No	A	Yes	6
5	31	Yes	A	Yes	7
6	51	Yes	A	Yes	2
7	35	No	A	Yes	6
8	44	No	A	Yes	4
9	37	No	A	Yes	4
10	50	Yes	D	No	7
11	38	No	A	Yes	5

^*Age at study entry

^†HCV = hepatitis C antibody positive

^‡YMDD: lamivudine resistance

^§Lamivudine duration at study end